Nano-HPLC-MS analysis of phospholipids in cerebrospinal fluid of Alzheimer's disease patients-a pilot study

Analytical and Bioanalytical Chemistry

Volumn 398, Issue 7-8, 2010, Pages 2929-2937

  Kosicek, M ^a   Kirsch, S ^b   Bene, R ^c   Trkanjec, Z ^c   Titlic, M ^d   Bindila, L ^b,e   Peter Katalinic, J ^b,f   Hecimovic, S ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^d UNIVERSITY HOSPITAL SPLIT   (Croatia)

^e LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^f University of Rijeka   (Croatia)

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Liquid chromatography; Mass spectrometry; Phospholipids; Sphingomyelin

Indexed keywords

ALZHEIMER'S DISEASE; BIOLOGICAL MATRIXES; CEREBRO SPINAL FLUIDS; CEREBROSPINAL FLUID; ELECTROSPRAYS; HPLC-MS; LIPID ALTERATION; LIPID SPECIES; NANOHPLC; NEURODEGENERATIVE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PILOT STUDIES; QUADRUPOLE-TIME OF FLIGHTS; REPRODUCIBILITIES; SENSITIVE DETECTION; SPHINGOMYELIN;

AMIDES; BODY FLUIDS; BRAIN; DISEASES; LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY;

PHOSPHOLIPIDS;

BIOLOGICAL MARKER; PHOSPHOLIPID;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NANOTECHNOLOGY; NONPARAMETRIC TEST; PILOT STUDY;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CEREBROSPINAL FLUID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; MIDDLE AGED; NANOTECHNOLOGY; PHOSPHOLIPIDS; PILOT PROJECTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STATISTICS, NONPARAMETRIC;

EID: 78650171191     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-010-4273-8     Document Type: Article

References (35)

1. MR Wenk 2005 The emerging field of lipidomics Nat Rev Drug Discov 4 594 610 1:CAS:528:DC%2BD2MXmsFGjtbs%3D 10.1038/nrd1776 (Pubitemid 40975712)
2. RM Adibhatla JF Hatcher RJ Dempsey 2006 Lipids and lipidomics in brain injury and diseases AAPS J 8 E314 E321
3. AD Postle 2009 Phospholipid lipidomics in health and disease Eur J Lipid Sci Technol 111 2 13 1:CAS:528:DC%2BD1MXitV2qsb0%3D 10.1002/ejlt.200800158
4. CP Ferri M Prince C Brayne H Brodaty L Fratiglioni M Ganguli K Hall K Hasegawa H Hendrie Y Huang A Jorm C Mathers PR Menezes E Rimmer M Scazufca Alzheimer's Disease International 2005 Global prevalence of dementia: a Delphi consensus study Lancet 366 2112 2117 10.1016/S0140-6736(05)67889-0 (Pubitemid 41797645)
5. JL Price JC Morris 1999 Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease Ann Neurol 45 358 368 1:STN:280:DyaK1M7ntValtQ%3D%3D 10.1002/1531-8249(199903)45:3<358::AID- ANA12>3.0.CO;2-X (Pubitemid 29120041)
6. J Hardy 2002 Testing times for the "amyloid cascade hypothesis" Neurobiol Aging 23 1073 1074 10.1016/S0197-4580(02)00042-8 (Pubitemid 35447788)
7. FJ Wippold 2nd N Cairns K Vo DM Holtzman JC Morris 2008 Neuropathology for the neuroradiologist: plaques and tangles AJNR Am J Neuroradiol 29 18 22 10.3174/ajnr.A0781
8. T Hartmann J Kuchenbecker MO Grimm 2007 Alzheimer's disease: the lipid connection J Neurochem 103 Suppl 1 159 170 1:CAS:528:DC%2BD2sXhtl2jurrL 10.1111/j.1471-4159.2007.04715.x
9. EG Zinser T Hartmann MO Grimm 2007 Amyloid beta-protein and lipid metabolism Biochim Biophys Acta 1768 1991 2001 1:CAS:528:DC%2BD2sXosF2gtLo%3D 10.1016/j.bbamem.2007.02.014 (Pubitemid 47161020)
10. X Han RW Gross 2003 Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics J Lipid Res 44 1071 1079 1:CAS:528:DC%2BD3sXltFarsr0%3D 10.1194/jlr.R300004-JLR200 (Pubitemid 37279625)
11. X Han MD Holtzman DW McKeel Jr J Kelley JC Morris 2002 Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis J Neurochem 82 809 818 1:CAS:528:DC%2BD38XmsF2htbY%3D 10.1046/j.1471-4159.2002.00997.x
12. X Han AM Fagan H Cheng JC Morris C Xiong DM Holtzman 2003 Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia Ann Neurol 54 115 119 1:CAS:528:DC%2BD3sXlvVWisrg%3D 10.1002/ana.10618 (Pubitemid 36764988)
13. H Satoi H Tomimoto R Ohtani T Kitano T Kondo M Watanabe N Oka I Akiguchi S Furuya Y Hirabayashi T Okazaki 2004 Astroglial expression of ceramide in Alzheimer's disease brains: a role during neuronal apoptosis Neuroscience 130 657 666 10.1016/j.neuroscience.2004.08.056
14. JW Pettegrew K Panchalingam RL Hamilton RJ McClure 2001 Brain membrane phospholipid alterations in Alzheimer's disease Neurochem Res 26 771 782 1:CAS:528:DC%2BD3MXmvFGhur8%3D 10.1023/A:1011603916962 (Pubitemid 32845968)
15. M Mulder R Ravid DF Swaab ER de Kloet ED Haasdijk J Julk JJ van der Boom LM Havekes 1999 Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4 Alzheimer Dis Assoc Disord 12 198 203 10.1097/00002093- 199809000-00012 (Pubitemid 29154989)
16. C Mulder LO Wahlund T Teerlink M Blomberg R Veerhuis GJ van Kamp P Scheltens PG Scheffer 2003 Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer's disease J Neural Transm 110 949 955 1:CAS:528:DC%2BD3sXlvVWqurk%3D 10.1007/s00702-003-0007-9 (Pubitemid 36981409)
17. A Walter U Korth M Hilgert J Hartmann O Weichel M Hilgert K Fassbender A Schmitt J Klein 2004 Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients Neurobiol Aging 25 1299 1303 1:CAS:528:DC%2BD2cXotFCmurY%3D 10.1016/j.neurobiolaging.2004.02.016 (Pubitemid 39299166)
18. G McKhann D Drachman M Folstein R Katzman D Price EM Stadlan 1984 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease Neurology 34 939 944 1:STN:280:DyaL2c3ks1altQ%3D%3D (Pubitemid 14076461)
19. AM Fagan CM Roe C Xiong MA Mintun JC Morris DM Holtzman 2007 Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults Arch Neurol 64 343 349 10.1001/archneur.64. 3.noc60123 (Pubitemid 46425688)
20. N Mattsson H Zetterberg O Hansson N Andreasen L Parnetti M Jonsson SK Herukka WM van der Flier MA Blankenstein M Ewers K Rich E Kaiser M Verbeek M Tsolaki E Mulugeta E Rosen D Aarsland PJ Visser J Schroder J Marcusson M de Leon H Hampel P Scheltens T Pirttila A Wallin ME Jonhagen L Minthon B Winblad K Blennow 2009 CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment JAMA 302 385 393 1:CAS:528:DC%2BD1MXptVCgu7Y%3D 10.1001/jama.2009.1064
21. V Matyash G Liebisch TV Kurzchalia A Shevchenko D Schwudke 2008 Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics J Lipid Res 49 1137 1146 1:CAS:528:DC%2BD1cXltFSltLY%3D 10.1194/jlr.D700041-JLR200
22. DR Illingworth J Glover 1972 The composition of lipids in cerebrospinal fluid of children and adults J Neurochem 18 769 776 10.1111/j.1471-4159.1971. tb12006.x
23. F Kunz E Rumpl 1973 Phospholipids in human cerebrospinal fluid Z Neurol 203 259 264 10.1007/BF00316117
24. KJ Zilkha B McArdle 1963 The phospholipid composition of cerebrospinal fluid in diseases associated with demyelination Q J Med 32 79 97 1:STN:280:DyaF387psFGmsA%3D%3D
25. D Seidel R Buck R Heipertz H Pilz 1980 Cerebrospinal fluid lipids in demyelinating disease. I. Sphingolipids 222 171 176 1:CAS:528:DyaL3cXhvFGqurY%3D (Pubitemid 10160394)
26. P Haimi A Uphoff M Hermansson P Somerharju 2006 Software tools for analysis of mass spectrometric lipidome data Anal Chem 78 8324 8331 1:CAS:528:DC%2BD28Xht1SqtLvI 10.1021/ac061390w (Pubitemid 44932100)
27. J Folch M Lees GH Sloane Stanley 1957 A simple method for the isolation and purification of total lipides from animal tissues J Biol Chem 226 497 509 1:STN:280:DyaG2s%2FnsFCjtw%3D%3D
28. BL Peterson BS Cummings 2006 A review of chromatographic methods for the assessment of phospholipids in biological samples Biomed Chromatogr 20 227 243 1:CAS:528:DC%2BD28XjtlKmu7g%3D 10.1002/bmc.563
29. S Kirsch M Zarei M Cindric J Muthing L Bindila J Peter-Katalinic 2008 On-line nano-HPLC/ESI QTOF MS and tandem MS for separation, detection, and structural elucidation of human erythrocytes neutral glycosphingolipid mixture Anal Chem 80 4711 4722 1:CAS:528:DC%2BD1cXmtFWgsbk%3D 10.1021/ac702175f (Pubitemid 351842351)
30. X Han DM Holtzman DW McKeel Jr 2001 Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry J Neurochem 77 1168 1180 1:CAS:528:DC%2BD3MXktVWitLo%3D 10.1046/j.1471-4159.2001.00332.x (Pubitemid 32467071)
31. AN Fonteh RJ Harrington AF Huhmer RG Biringer JN Riggins MG Harrington 2006 Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods Dis Markers 22 39 64 1:CAS:528: DC%2BD2MXhtlCnsrrP (Pubitemid 41831604)
32. K Wells AA Farooqui L Liss LA Horrocks 1996 Neural membrane phospholipids in Alzheimer disease Neurochem Res 20 1329 1333 10.1007/BF00992508
33. MR Prasad MA Lovell M Yatin H Dhillon WR Markesbery 1998 Regional membrane phospholipid alterations in Alzheimer's disease Neurochem Res 23 81 88 1:CAS:528:DyaK1cXosV2htg%3D%3D 10.1023/A:1022457605436 (Pubitemid 28145695)
34. RG Cutler J Kelly K Storie WA Pedersen A Tammara K Hatanpaa JC Troncoso MP Mattson 2004 Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease Proc Natl Acad Sci USA 101 2070 2075 1:CAS:528:DC%2BD2cXhs1Srsrw%3D 10.1073/pnas.0305799101 (Pubitemid 38229016)
35. MM Mielke VV Bandaru NJ Haughey PV Rabins CG Lyketsos MC Carlson 2009 Serum sphingomyelins and ceramides are early predictors of memory impairment Neurobiol Aging 31 17 24 10.1016/j.neurobiolaging.2008.03.011